Friday, Dec 09, 2022

New drug may treat both diabetes and bone loss

The new dual-targeting drug candidate, referenced as "SR10171.", could treat both diabetes and bone disease.

Dilshad Garden, blood sugar, diabetic families, joint families, nuclear families, Type 2 diabetes mellitus, diabetes, T2DM, health news, India news, national news, latest news, Delhi news Improve body mass index and treat diabetes. (File)

Researchers have developed a new class of compound that has shown promise in treating both diabetes and bone disease.

In addition to its more obvious ills, Type-2 diabetes is a condition closely associated with bone fractures, increasing the risk of fractures twofold. To make matters worse, certain anti-diabetic drugs further increase this risk, particularly in postmenopausal women, severely limiting their treatment options.

But the new dual-targeting drug candidate, referenced as “SR10171.”, could treat both diabetes and bone disease. “SR10171 improves bone mass regardless of body mass index, normal to obese,” said co-lead researcher Patrick Griffin, professor at the Florida campus of The Scripps Research Institute (TSRI) in the US.

“So you could use such a drug to treat osteoporosis whether patients are diabetic or not,” Griffin added. The drug increases bone mass by expanding bone formation (deposition of new bone) and bone turnover (a normal process of replacement of old bone).

Subscriber Only Stories
JK Cement’s SPSU Udaipur Launches ‘Golden Batch 2022’ In Collaboration Wi...Premium
Appendicitis in Children- A new lifestyle disorderPremium
Using evidence will create strong foundations for the future of education...Premium
Re-Defining The Tradition In Folk Art: An Art Educator’s PerspectivePremium

A proper balance of these two processes is critical to healthy bone maintenance, and this balance is frequently negatively affected in diabetic patients. In animal models treated with the compound, fat formation in the bone marrow was successfully blocked independent of their metabolic state (healthy or diabetic), showed the study published online in the journal EbioMedicine.

First published on: 28-07-2016 at 02:28:15 pm
Next Story

We are in dangerous times: Harsha Bhogle’s message on responsible journalism is a must read

Latest Comment
Post Comment
Read Comments
search Search